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Abstract
Background: To examine the relation between self-reported hypoglycemic events, worries about these episodes,
and the burden of diabetes in adults with diabetes and family members from The Netherlands.
Methods: As part of the second multinational Diabetes Attitudes, Wishes and Needs (DAWN2) study, 412 Dutch
adults with type 1 or type 2 diabetes and 86 family members completed questions about the burden of living with
diabetes, the frequency of hypoglycemia, worries about these events, and several demographic and clinical factors.
Analyses included hierarchical logistic regression.
Results: In total, 41% of people with diabetes and 56% of family members considered diabetes at least somewhat
of a burden. In people with diabetes, diabetes burden was independently associated with self-reported current insulin
use (fully adjusted OR = 2.75, 95% CI 1.49–5.10), self-reported frequent non-severe hypoglycemia in the past year (OR =
2.45, 1.25–4.83), self-reported severe hypoglycemia in the past year (OR = 1.91, 1.02–3.58), and being very worried about
hypoglycemia at least occasionally (OR = 3.64, 2.18–6.10). For family members, the odds of experiencing living with
diabetes as a burden was increased only for participants who were at least occasionally very worried about
hypoglycemia (adjusted OR = 5.07, 1.12–23.00).
Conclusions: Approximately half of adults with diabetes and adult family members experienced at least some diabetes
burden. In both groups, diabetes burden appeared to be associated with being very worried about hypoglycemia at
least occasionally. If these results are replicated, new intervention studies could test new ways of decreasing
the traumatic consequences of previous or anticipated hypoglycemic events for people with diabetes and
family members.
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Background
Despite ongoing improvements in technology and care,
living with diabetes remains a challenge for many
people. The second Diabetes Attitudes, Wishes and
Needs (DAWN2) study among 8596 adults with diabetes
across 17 countries found that 12% of participants
reported poor or very poor overall quality of life, 14%
had likely depression and 45% showed high diabetes-
specific distress [1]. In addition, diabetes had a negative
impact on all examined aspects of life, including physical
health and relationships [1]. Diabetes and its treatment
not only affect the person living with this condition, but
may also have an impact on family members [2]. The
DAWN2 study surveyed 2057 adult family members and
found that over one third perceived a considerable bur-
den of diabetes on the family [3]. People with diabetes
and their family members may experience a range of
worries about risks connected with diabetes, with
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hypoglycemia featuring as one of the key themes
(Hermanns et al., submitted; [4]).
Hypoglycemia remains the greatest barrier to achiev-
ing and maintaining tight glycemic control in people
with type 1 diabetes and people with type 2 diabetes on
insulin therapy or sulfonylurea treatment [5]. The preva-
lence of severe hypoglycemia (requiring assistance from
another person for recovery [6]) varies according to
diabetes type and treatment duration, ranging from 7%
in people with type 2 diabetes using sulfonylurea or in-
sulin for less than 2 years to 46% in those with long-
standing type 1 diabetes (> 15 years) [7]. Non-severe
hypoglycemia (events manageable by the person with
diabetes) is also an important problem as symptoms can
be unpleasant and aversive, and may interfere with fol-
lowing treatment recommendations [8, 9].
Findings of the international DAWN2 study among
adults with diabetes and family members of people with
diabetes suggest psychological outcomes are worse when
hypoglycemia is more frequent [10, 11]. However, sub-
stantial between-country variation in outcomes and as-
sociations in these studies underlines the need for
country-specific analyses [10, 11]. Therefore, the present
study used data from the Dutch sample of the DAWN2
study to examine the relation between the frequency of
hypoglycemia, worries about these events, and the bur-
den of diabetes in adults with diabetes and family mem-
bers from The Netherlands.
Methods
Procedure and participants
The second Diabetes Attitudes Wishes and Needs
(DAWN2) study used a cross-sectional questionnaire
survey in 17 countries across four continents, to exam-
ine the attitudes, wishes and needs of people with dia-
betes, family members and healthcare professionals [12].
Design and procedures for the Dutch sub study were in
line with the international study protocol [12]. For the
sample of people with diabetes, inclusion criteria were
age ≥ 18 years, a diagnosis of (non-gestational) diabetes
by a healthcare professional at least 12 months ago, and
disclosure of current diabetes treatment. For the sample
of family members, inclusion criteria were age ≥ 18 years,
not having diabetes yourself, living in the same house-
hold with an adult with (non-gestational) diabetes diag-
nosed at least 12 months ago, and being involved in
their diabetes care. Potential participants were initially
identified via existing panels and databases. Individuals
were then contacted via email or by phone. Interviews
were conducted online (self-administered), by phone, or
face-to-face (for a small number). The study was con-
ducted in accordance with ethical requirements and all
participants provided informed consent.
The Dutch subsamples included 502 adults with dia-
betes and 120 family members. For the present analyses,
we excluded people taking injectables other than insulin
(“non-insulin injectables”, e.g. GLP-1 agonists) as there
were relatively few of them (n = 15) and their data might
cloud the results. We also excluded people not meeting
the definition of type 1 and type 2 diabetes as employed
in DAWN2 [1]. Type 1 diabetes was defined as self-
reported (a) diagnosis before the age of 30, (b) prescrip-
tion of insulin when first diagnosed, and (c) current in-
sulin use. Type 2 diabetes was defined as self-reported
(a) diagnosis on or after the age of 30, and (b) no pre-
scription of insulin when first diagnosed. This left 412
people with diabetes and 86 family members.
Measurements
Diabetes burden
As a proxy of diabetes burden in people with diabetes,
we used an item from the Problem Areas in Diabetes
questionnaire [13]. Participants were asked to indicate
on a five-point Likert scale ranging from “not a prob-
lem” to “serious problem” whether “Feeling that diabetes
is taking up too much of your mental and physical en-
ergy every day” was currently a problem for them. Dia-
betes was considered a burden if participants reported a
minor, moderate, somewhat serious, or serious problem.
We preferred the pooling of people with minor and
major concerns over the pooling of people with minor
and no concerns, as this last approach would ignore a
group who do report a problem (albeit not of major pro-
portions). Family members were asked to indicate on a
five-point Likert scale ranging from “no burden” to “very
large burden” how much of a burden it was for them to
help manage the diabetes of the person they lived with.
Diabetes was considered a burden if participants re-
ported a slight, moderate, large or very large burden.
Hypoglycemic events
People with diabetes and family members were asked to
report the average number of times the person with dia-
betes has had symptoms of hypoglycemia, which they
could treat themselves during the past 12 months. Based
on clinical experience and the distribution of replies, fre-
quency of non-severe hypoglycemia was categorized as
“none” (no symptoms in past 12 months), “occasional”
(once a month, less often than once a month) and “fre-
quent” (at least once a day, at least once a week, several
times a month). In addition, both groups were asked to
report approximately how many times during the past
12 months the person with diabetes has had severely
low blood sugar that he/she was unable to treat himself/
herself and needed help from someone to restore blood
sugar levels. Severe hypoglycemia during the past
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12 months was categorized as “no” versus “one or more
events”.
Worries about hypoglycemia
People with diabetes and family members were asked to
rate on a four-point Likert scale to what extent they
agreed with the statement “I am very worried about the
risk of [him/her having] hypoglycemic (low blood sugar)
events”. When they mainly disagreed, mainly agreed and
fully agreed with the statement, this was taken to indi-
cate the presence of at least some worries about
hypoglycemia.
Demographic and clinical covariates
For both people with diabetes and family members, vari-
ables included gender, age, educational level (with a high
level defined as having completed higher vocational edu-
cation or university), working full or part-time (no/yes),
and whether the person with diabetes was using insulin
to manage diabetes (no/yes). For people with diabetes,
additional information included whether they were cur-
rently living with somebody (no/yes), diabetes duration,
and the presence of one or more (potentially diabetes-
related) co-morbid conditions (stroke, foot ulcer, foot/
leg amputation, kidney disease, eye damage, nerve dam-
age, heart disease).
Statistical analyses
Two separate hierarchical (blockwise) logistic regression
analyses were used (one for people with diabetes and
one for family members) to examine the association of
hypoglycemic events and worries about hypoglycemia
with diabetes burden. For family members, step 1
included gender, age, educational level, employment,
insulin use, non-severe hypoglycemia and severe
hypoglycemia. In step 2, worries about hypoglycemia
were added. For people with diabetes, living situation,
diabetes duration and co-morbidities were also included
in step 1. All analyses were performed using SPSS
Version 22 (IBM SPSS Statistics, New York). A p-value
< 0.05 indicated statistical significance.
Results
Sample characteristics
Descriptive characteristics of the samples of adults with
diabetes and family members are displayed in Table 1.
Table 1 Descriptive characteristics of the sample of adults with diabetes and adult family members
Missing values Adults with diabetes (n = 412) Missing values Family members (n = 86)
Female gender 0 48% (197) 0 83% (71)
Age, years 0 60 ± 11 (62, 54–67) 0 54 ± 13 (56, 50–62)
High educational level 17 26% (102) 3 35% (29)
Living alone 0 27% (113) NA
Working full- or parttime 2 27% (112) 0 38% (33)
Diabetes type and treatment 0 0
Type 2 diabetes, no medication 22% (91) 15% (13)
Type 2 diabetes, oral medication only 36% (150) 51% (44)
Type 2 diabetes, insulin 22% (91) 26% (22)
Type 1 diabetes 19% (80) 8% (7)
Diabetes duration, years 0 13 ± 12 (9, 4–17) NA
Co-morbidities 0 NA
No 45% (184)
One 30% (125)
Two or more 25% (103)
Non-severe hypoglycemia in past year 3 5
None 33% (134) 40% (32)
Occasional 32% (132) 36% (29)
Frequent 35% (143) 25% (20)
Severe hypoglycemia in past year (≥1 event) 1 20% (83) 22 30% (19)
Worries about hypoglycemia 19 57% (225) 7 61% (48)
Diabetes burden 0 41% (170) 0 56% (48)
NA not applicable/available
Values are % (n) or mean ± SD (median, interquartile range)
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Compared to people with diabetes, family members ap-
peared to be more likely to be female, to have a high
educational level, and to be employed, and were some-
what younger. In the sample of people with diabetes,
participants with type 1 diabetes were somewhat over-
represented compared to national estimates [14]. People
with diabetes were somewhat more likely to report fre-
quent non-severe hypoglycemia, while family members
more commonly indicated that the person with diabetes
they lived with had experienced severe hypoglycemia
during the past 12 months. Approximately 60% of
people with diabetes and family members were at least
occasionally very worried about hypoglycemia, while liv-
ing with diabetes was a small to large burden for half of
participants in both groups.
Diabetes burden in people with diabetes
When the frequency of non-severe and severe
hypoglycemia were entered in step 1 along with the
demographic and clinical covariates, this first model was
statistically significant (χ2(12) = 72, p < 0.001; Cox and
Snell R square = 0.17; Nagelkerke R square = 0.23). As
shown in Table 2, participants who used insulin (p =
0.003), who experienced frequent non-severe
hypoglycemia during the past 12 months (compared to
people reporting none of these events; p < 0.001) and
who had experienced a severe hypoglycemic event dur-
ing the past 12 months (p = 0.02) had higher odds of
considering diabetes at least somewhat of a burden, ad-
justed for the other variables in model 1. Entry of wor-
ries about hypoglycemia in step 2 led to a significant
model improvement (change χ2(1) = 26, p < 0.001; Cox
and Snell R square = 0.23; Nagelkerke R square = 0.31).
In this fully adjusted model (χ2(13) = 98, p < 0.001), par-
ticipants who used insulin (p = 0.001), who experienced
frequent non-severe hypoglycemia during the past
12 months (compared with people reporting none of
these events; p = 0.009), who had experienced a severe
hypoglycemic event during the past 12 months (p =
0.04), and who were at least occasionally very worried
about hypoglycemia (p < 0.001) had higher odds of con-
sidering diabetes at least somewhat of a burden.
Diabetes burden in family members
When the frequency of non-severe and severe
hypoglycemia were entered in step 1 along with the
demographic and clinical covariates, this first model was
not statistically significant (χ2(8) = 8, p = 0.42; Cox and
Snell R square 0.13; Nagelkerke R square 0.18). As
shown in Table 2, none of the demographic and clinical
variables in this step were independently associated with
diabetes burden in family members. Entry of worries
about hypoglycemia in step 2 led to a significant model
improvement (change χ2(1) = 5, p = 0.03; Cox and Snell
R square = 0.20; Nagelkerke R square = 0.27). However,
this fully adjusted model was still not statistically
Table 2 The relation between demographic, clinical and psychological factors and the burden of diabetes
Adults with diabetes (n = 377) Family members (n = 58)
Model 1 Model 2 Model 1 Model 2
Female gender 1.04 (0.64–1.69) 1.08 (0.65–1.79) 1.24 (0.23–6.87) 1.00 (0.16–6.12)
Age, years 0.98 (0.95–1.01) 0.98 (0.95–1.01) 0.99 (0.94–1.04) 0.98 (0.93–1.03)
High educational level 0.92 (0.53–1.58) 1.09 (0.62–1.94) 0.53 (0.13–2.11) 0.99 (0.21–4.66)
Living alone 1.24 (0.74–2.09) 1.23 (0.71–2.10) NA NA
Working full- or parttime 0.70 (0.39–1.24) 0.66 (0.36–1.20) 1.67 (0.43–6.44) 0.98 (0.22–4.35)
Diabetes duration, years 0.99 (0.97–1.01) 0.99 (0.96–1.01) NA NA
Using insulin 2.45 (1.36–4.41) 2.75 (1.49–5.10) 1.57 (0.37–6.77) 0.86 (0.17–4.35)
Co-morbidities NA NA
No Ref Ref
One 1.36 (0.79–2.35) 1.36 (0.77–2.38)
Two or more 1.00 (0.54–1.86) 1.04 (0.55–1.98)
Non-severe hypoglycemia in past year
None Ref Ref Ref Ref
Occasional 1.75 (0.95–3.23) 1.33 (0.70–2.52) 1.15 (0.26–5.06) 0.69 (0.13–3.53)
Frequent 3.55 (1.87–6.76) 2.45 (1.25–4.83) 3.84 (0.65–22.79) 1.52 (0.20–11.34)
Severe hypoglycemia in past year (≥1 event) 2.00 (1.09–3.66) 1.91 (1.02–3.58) 1.51 (0.34–6.78) 2.28 (0.44–11.87)
Worries about hypoglycemia 3.64 (2.18–6.10) 5.07 (1.12–23.00)
NA not applicable/available
Hierarchical logistic regression analyses. Values are OR (95% CI); bold = statistically significant (p < 0.05)
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significant (χ2(9) = 13, p = 0.16). Family members who
were at least occasionally very worried about
hypoglycemia (p = 0.04) had higher odds of considering
diabetes at least somewhat of a burden, adjusted for the
other variables in model 2.
Discussion
This study based on the Dutch subsample of the inter-
national DAWN2 study found that almost half of adults
with diabetes considered diabetes at least somewhat of a
burden. A direct comparison with figures from other
countries is difficult to make. While we based the defin-
ition of diabetes burden on one item focusing on the
mental and physical costs of living with this condition,
the cross-national benchmarking paper of the DAWN2
study considered several more global measures including
the composite score of the Problem Areas in Diabetes 5
item version and the DAWN Impact of Diabetes Profile
[1]. Countries ranked differently across these different
indicators of diabetes burden, where no individual coun-
try or region appeared to be consistently better or worse
than the others [1]. Overall, the Dutch sample appeared
to be among the quarter of countries with the most opti-
mal scores in this domain [1]. With respect to family
members, we found that more than half of the Dutch
participants indicated at least some burden in helping
the person with diabetes they lived with managing their
diabetes. The international DAWN2 papers employed a
more strict definition of burden, finding 35% of the total
sample reporting a moderate to very large burden [3],
with the Dutch subsample scoring slightly under the
total mean [3].
In participants with diabetes, we found a positive
association between self-reported insulin use and
experienced diabetes burden, adjusted for the other
variables. Previous studies have suggested that insulin
therapy is viewed as the most burdensome treatment
modality among people with type 2 diabetes [15]. While
negative appraisals of insulin therapy are highest among
those who do not have previous experience with insulin
therapy, people who are currently using insulin or have
prior experience with this treatment modality still
experience substantial negative views about insulin [15–
17]. In the present study, the relation between self-
reported insulin use and diabetes burden was independ-
ent of worries about hypoglycemia and self-reported
occurrence of severe and non-severe hypoglycemic
events in the previous year, suggesting other aspects of
insulin treatment might play a role. For example, in the
Diabetes MILES – Australia study half of participants
with type 2 diabetes using insulin believed that taking
insulin meant their diabetes had become worse and that
insulin caused weight gain [16]. Furthermore, approxi-
mately 25% of adults with type 1 or insulin-treated type
2 diabetes experience injection-related anxiety [18, 19].
In addition, both of these groups frequently have to cope
with actual or anticipated negative attention and judg-
ment from others when self-injecting insulin by pen or
pump [20–22].
With respect to hypoglycemia, previous studies have
mostly focused on the psychological impact of severe
events, finding a relation with greater diabetes-related
distress and poorer general emotional well-being [23]. A
large European study among people with type 1 diabetes
and insulin-treated type 2 diabetes showed that non-
severe hypoglycemia may also have a substantial negative
impact on energy and mood [24]. In the present study,
people with diabetes also had increased odds of diabetes
burden not only when they had experienced at least one
self-reported severe hypoglycemic event, but also in case
of self-reported frequent non-severe hypoglycemia dur-
ing the past 12 months, adjusted for the other variables.
The relation between proxy-reported hypoglycemic
events and diabetes burden was not found in family
members. This may be explained by the relatively small
number of family members available for the regression
analysis. Alternatively, it is possible that family members
have not been aware of all hypoglycemic events that
have occurred. From previous studies, it is known that
people with diabetes and their family members often dis-
agree about the frequency and nature of hypoglycemic
episodes [25, 26].
In both people with diabetes and family members,
more worries about hypoglycemia were associated with
higher diabetes burden, adjusted for the other variables.
While the recent occurrence of hypoglycemic events has
been associated with higher worries about hypoglycemia
[23, 27, 28], the relation between worries about
hypoglycemia and diabetes burden was independent of
the occurrence of self- or proxy-reported severe and
non-severe hypoglycemic events in the past year. Several
studies from the pediatric diabetes literature suggest
that, apart from the frequency of events, the types of ex-
periences with hypoglycemia (e.g. with seizures or un-
consciousness) may determine the level of experienced
worries about future events [29–31]. A study among 90
adults with type 1 diabetes found that over 25% met
diagnostic criteria of hypoglycemia-specific posttrau-
matic stress and reported that perceived threat of death
from hypoglycemia and fear of hypoglycemia were sig-
nificantly related to these symptoms, while number of
recent hypoglycemic episodes was not [32]. From the
scientific literature on posttraumatic stress we know that
it is also possible to experience symptoms triggered by
anticipatory thoughts about future distressing events
[33]. In family members, the extent to which they be-
lieve their relative with diabetes is able to cope with
hypoglycemic episodes may also be an important
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determinant of the level of experienced worries about
hypoglycemia. This hypothesis is supported by literature
from the pediatric diabetes field, where trait anxiety
levels and recent experiences with hypoglycemia pre-
dicted fear of hypoglycemia in adolescents with type 1
diabetes but beliefs about whether their child carried
emergency glucose were associated with fear of
hypoglycemia in parents [29].
The findings of this study should be considered in
terms of its limitations and strengths. First, while cross-
country variations in outcomes necessitate the additional
analysis for specific countries, the number of participat-
ing family members from the Netherlands was relatively
low. This may have significantly underpowered the
present analyses. Similarly, the number of participants in
the present study does not allow stratifying the analyses
for diabetes type. Also, unfortunately, the distribution of
replies on the items about burden and worries and the
increased number of analyses did not allow sensitivity
analyses in which different definitions were used. Sec-
ond, we had to rely on self- or proxy report about clin-
ical variables such as diabetes type. Our decision to
adhere to the previously used DAWN2 definitions of
type 1 and type 2 diabetes based on age of diagnosis, in-
sulin use shortly after diagnosis, and current insulin use
[1] may have safeguarded against some of the biases in-
herent to self- or proxy report. However, we may have
wrongfully excluded participants who would have quali-
fied as type 1 or type 2 diabetes based on laboratory
data, but diverge from the standard clinical picture on
which the DAWN2 diabetes definitions were based. Fur-
thermore, in this questionnaire-based study no objective
clinical data (e.g. glycemic control, use of continuous
glucose monitor) was available. Third, we used different
definitions of diabetes burden in people with diabetes
and family members, which makes a direct comparison
of prevalence and correlates across these groups more
difficult. Fourth, the main measures were based on sin-
gle purpose-designed items rather than validated ques-
tionnaires. The one-item question from the PAID has
not been officially validated as a proxy for diabetes bur-
den, but was selected based on experience with the
measure in clinical practice. Fifth, as one reviewer elo-
quently stated, “correlation does not mean causation”.
While we make some suggestions to guide intervention
in the following paragraph, an experimental design is
needed to establish whether manipulating worries about
hypoglycemia actually lowers perceived disease burden.
Finally, the results (especially for family members)
should be interpreted with caution in light of several
statistical considerations. Given the exploratory nature
of the study, we did not adjust for multiple testing, with
increased risk of type 1 errors. In addition, the number
of observations is small relative to the number of
predictors, increasing the risk of overfitting. The regres-
sion analysis for family members was run with a rela-
tively high number of predictors to ensure optimal
comparability with the analysis in people with diabetes,
but it is prudent to repeat the analysis based on the
larger international family members data set before
strong conclusions are drawn. Also, even though we
found a significant association between worries about
hypoglycemia and diabetes burden in family members, it
should be kept in mind that the test of the overall null
for family members was not statistically significant.
Strengths of the study include the focus on both people
with diabetes and adult family members and the diverse
demographic, (albeit self-reported) clinical and psycho-
logical correlates that were considered.
Most existing educational programs and behavioral in-
terventions in the field of hypoglycemia to date have pri-
marily focused on the avoidance of future events or
improved awareness. These have generally found a re-
duction in the number of hypoglycemic episodes and an
improvement in awareness, while improvements in wor-
ries about hypoglycemia were less consistent [34–37].
New technologies such as continuous glucose monitor-
ing and sensor-augmented pump therapy have shown
some promise in reducing hypoglycemia-related worries,
but results are inconsistent and a more thorough evalu-
ation of their potential with respect to patient-reported
outcomes is warranted [38]. As memories of previous
traumatic hypoglycemic events may be difficult to over-
come, a focus on the prevention and management of
hypoglycemia may not be enough to reduce fear of
hypoglycemia for all adults with diabetes [38]. In this
context, the anxiety and stress reducing properties of
eye movement desensitization and reprocessing treat-
ment should be explored further [33]. Interventions
could also target worries about hypoglycemia in adult
family members, as these may lead to suboptimal psy-
chological outcomes of family members as well as sub-
optimal diabetes support [4, 11].
Conclusions
In conclusion, approximately half of adults with diabetes
and adult family members experienced at least some dia-
betes burden. In both groups, being very worried about
hypoglycemia at least occasionally appeared to be inde-
pendently associated with diabetes burden. Other signifi-
cant independent correlates with higher diabetes burden
in people with diabetes included self-reported insulin
use, self-reported frequent non-severe hypoglycemia and
self-reported severe hypoglycemia. The merits of new
technologies and educational / behavioral interventions
with a primary focus on the prevention of hypoglycemic
events and improved hypoglycemia awareness in redu-
cing fear of hypoglycemia need to be explored further.
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However, these could be supplemented with intervention
studies that test new treatments targeting the traumatic
consequences of previous or future anticipated events
and hypoglycemia (self )-efficacy. The role and worries of
family members may also be considered. Given the
disappointing reproducibility of scientific findings [39],
replication of results is an important first step in this
process.
Abbreviations
DAWN2 study: the second Diabetes Attitudes, Wishes and Needs study
Acknowledgements
The authors thank all people with diabetes and family members who
participated in DAWN2. The authors wish to acknowledge the contribution
to the design and execution of the DAWN2 study of the DAWN2 Study
Group (consisting of a lead national investigator from each country and
members of the DAWN2 International Publication Planning Committee),
Harris Interactive Inc., Bioscript Medical Ltd., the International Diabetes
Federation and the numerous international and national experts and patient
advocates.
Funding
The DAWN2 study is funded by Novo Nordisk A/S. In collaboration with
national, regional and global partners, Novo Nordisk has assisted with the
planning and designing of the DAWN2 study. Data collection was
independently performed by Harris Interactive, who were funded by Novo
Nordisk. Data analysis and manuscript preparation were performed by the
authors.
Availability of data and materials
The data that support the findings of this study are available from Novo
Nordisk but restrictions apply to the availability of these data, which were
used under license for the current study, and so are not publicly available.
Data are however available from the authors upon reasonable request and
with permission of Novo Nordisk.
Authors’ contributions
GN and FP contributed to the conception and design of the study, analysis
and interpretation of the data; drafted the first version of the manuscript;
critically revised the manuscript for important intellectual content; and
approved the final version for publication. Both authors take responsibility
for the contents of the article.
Ethics approval and consent to participate
The DAWN2 study was conducted in accordance with the relevant national/
regional/local guidelines relating to the conduct of non-interventional studies,
using the guidelines of the International Chamber of Commerce / European
Society for Opinion and Marketing Research, the Council of American Survey
Research Organizations, and Good Pharmacoepidemiology Practices (UTN No:
U1111–1123-7509; NCT01507116). All participants provided informed consent. The
data were used with permission of Novo Nordisk.
Consent for publication
Not applicable
Competing interests
GN reports no conflict of interest. FP has received funding for travel and
accommodation to attend DAWN2 International Publication Planning
Committee meetings. His research group received a research grant from
Novo Nordisk to conduct statistical analyses and describe results of the
DAWN2 study and submit this work for publication.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1CoRPS - Center of Research on Psychological and Somatic disorders,
Department of Medical and Clinical Psychology, Tilburg University, PO BOX
90153, 5000 LE Tilburg, the Netherlands. 2Diabeter, National treatment and
research center for children, adolescents and young adults with type 1
diabetes, Rotterdam, The Netherlands. 3Radboud university medical center,
Radboud Institute for Health Sciences, Department of Medical Psychology,
Nijmegen, The Netherlands. 4Department of Psychology, University of
Southern Denmark, Odense, Denmark.
Received: 19 January 2017 Accepted: 10 January 2018
References
1. Nicolucci A, Kovacs Burns K, Holt RI, Comaschi M, Hermanns N, Ishii H,
Kokoszka A, Pouwer F, Skovlund SE, Stuckey H, et al. Diabetes attitudes,
wishes and needs second study (DAWN2): cross-national benchmarking of
diabetes-related psychosocial outcomes for people with diabetes. Diabet
Med. 2013;30(7):767–77.
2. Rintala TM, Jaatinen P, Paavilainen E, Astedt-Kurki P. Interrelation between
adult persons with diabetes and their family: a systematic review of the
literature. J Fam Nurs. 2013;19(1):3–28.
3. Kovacs Burns K, Nicolucci A, Holt RI, Willaing I, Hermanns N, Kalra S, Wens J,
Pouwer F, Skovlund SE, Peyrot M. Diabetes attitudes, wishes and needs
second study (DAWN2): cross-national benchmarking indicators for family
members living with people with diabetes. Diabet Med. 2013;30(7):778–88.
4. Nefs G, Pouwer F, Holt RI, Skovlund S, Hermanns N, Nicolucci A, Peyrot M.
Correlates and outcomes of worries about hypoglycemia in family members
of adults with diabetes: the second diabetes attitudes, wishes and needs
(DAWN2) study. J Psychosom Res. 2016;89:69–77.
5. Frier BM. How hypoglycaemia can affect the life of a person with diabetes.
Diabetes Metab Res Rev. 2008;24(2):87–92.
6. Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, Heller SR,
Rodriguez H, Rosenzweig J, Vigersky R. Hypoglycemia and diabetes: a report
of a workgroup of the American Diabetes Association and the Endocrine
Society. Diabetes Care. 2013;36(5):1384–95.
7. UK Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and 2
diabetes: effects of treatment modalities and their duration. Diabetologia.
2007;50(6):1140–7.
8. McAulay V, Deary IJ, Frier BM. Symptoms of hypoglycaemia in people with
diabetes. Diabet Med. 2001;18(9):690–705.
9. Alvarez Guisasola F, Tofe Povedano S, Krishnarajah G, Lyu R, Mavros P, Yin D.
Hypoglycaemic symptoms, treatment satisfaction, adherence and their
associations with glycaemic goal in patients with type 2 diabetes mellitus:
findings from the real-life effectiveness and care patterns of diabetes
management (RECAP-DM) study. Diabetes Obes Metab. 2008;10(Suppl 1):
25–32.
10. Nicolucci A, Kovacs Burns K, Holt RI, Lucisano G, Skovlund SE, Kokoszka A,
Massi Benedetti M, Peyrot M. Correlates of psychological outcomes in
people with diabetes: results from the second diabetes attitudes, wishes
and needs (DAWN2) study. Diabet Med. 2016;33(9):1194–203.
11. Kovacs Burns K, Holt RI, Nicolucci A, Lucisano G, Skovlund SE, Comaschi M,
Vallis M, Peyrot M. Correlates of psychological outcomes among family
members of people with diabetes in the second diabetes attitudes, wishes
and needs (DAWN2) study. Diabet Med. 2016;33(9):1184–93.
12. Peyrot M, Burns KK, Davies M, Forbes A, Hermanns N, Holt R, Kalra S,
Nicolucci A, Pouwer F, Wens J, et al. Diabetes attitudes wishes and needs 2
(DAWN2): a multinational, multi-stakeholder study of psychosocial issues in
diabetes and person-centred diabetes care. Diabetes Res Clin Pract. 2013;
99(2):174–84.
13. Snoek FJ, Pouwer F, Welch GW, Polonsky WH. Diabetes-related emotional
distress in Dutch and U.S. diabetic patients: cross-cultural validity of the
problem areas in diabetes scale. Diabetes Care. 2000;23(9):1305–9.
14. Diabetes in cijfers [https://www.diabetesfonds.nl/over-diabetes/diabetes-in-
het-algemeen/diabetes-in-cijfers].
15. Vijan S, Hayward RA, Ronis DL, Hofer TP. Brief report: the burden of diabetes
therapy: implications for the design of effective patient-centered treatment
regimens. J Gen Intern Med. 2005;20(5):479–82.
16. Holmes-Truscott E, Skinner TC, Pouwer F, Speight J. Negative appraisals of
insulin therapy are common among adults with type 2 diabetes using
Nefs and Pouwer BMC Public Health  (2018) 18:156 Page 7 of 8
insulin: results from diabetes MILES - Australia cross-sectional survey. Diabet
Med. 2015;32(10):1297–303.
17. Holmes-Truscott E, Skinner TC, Pouwer F, Speight J. Explaining psychological
insulin resistance in adults with non-insulin-treated type 2 diabetes: the
roles of diabetes distress and current medication concerns. Results from
diabetes MILES–Australia. Prim Care Diabetes. 2016;10(1):75–82.
18. Zambanini A, Newson RB, Maisey M, Feher MD. Injection related anxiety in
insulin-treated diabetes. Diabetes Res Clin Pract. 1999;46(3):239–46.
19. Mollema ED, Snoek FJ, Ader HJ, Heine RJ, van der Ploeg HM. Insulin-
treated diabetes patients with fear of self-injecting or fear of self-
testing: psychological comorbidity and general well-being. J Psychosom
Res. 2001;51(5):665–72.
20. Browne JL, Ventura A, Mosely K, Speight J. ‘I call it the blame and shame
disease’: a qualitative study about perceptions of social stigma surrounding
type 2 diabetes. BMJ Open. 2013;3(11):e003384.
21. Browne JL, Ventura A, Mosely K, Speight J. ‘I’m not a druggie, I’m just a
diabetic’: a qualitative study of stigma from the perspective of adults with
type 1 diabetes. BMJ Open. 2014;4(7):e005625.
22. Browne JL, Ventura AD, Mosely K, Speight J. Measuring the stigma
surrounding type 2 diabetes: development and validation of the type
2 diabetes stigma assessment scale (DSAS-2). Diabetes Care. 2016;
39(12):2141–8.
23. Hendrieckx C, Halliday JA, Bowden JP, Colman PG, Cohen N, Jenkins A,
Speight J. Severe hypoglycaemia and its association with psychological
well-being in Australian adults with type 1 diabetes attending specialist
tertiary clinics. Diabetes Res Clin Pract. 2014;103(3):430–6.
24. Geelhoed-Duijvestijn P, Pedersen-Bjergaard U, Weitgasser R, Lahtela J,
Markert Jensen M, Ostenson CG. Effects of patient-reported non-severe
hypoglycemia on healthcare resource use, work-time loss, and wellbeing in
insulin-treated patients with diabetes in severe European countries. J Med
Econ. 2013;16(12):1453–61.
25. Heller S, Chapman J, McCloud J, Ward J. Unreliability of reports of
hypoglycaemia by diabetic patients. BMJ. 1995;310(6977):440.
26. Jorgensen HV, Pedersen-Bjergaard U, Rasmussen AK, Borch-Johnsen K. The
impact of severe hypoglycemia and impaired awareness of hypoglycemia
on relatives of patients with type 1 diabetes. Diabetes Care. 2003;26(4):
1106–9.
27. Nefs G, Bevelander S, Hendrieckx C, Bot M, Ruige J, Speight J, Pouwer F.
Fear of hypoglycaemia in adults with type 1 diabetes: results from diabetes
MILES - The Netherlands. Diabet Med. 2015;32(10):1289–96.
28. Sakane N, Kotani K, Tsuzaki K, Nishi M, Takahashi K, Murata T, Yamada K,
Okazaki K, Yanagisawa K, Yamada K, et al. Fear of hypoglycemia and its
determinants in insulin-treated patients with type 2 diabetes mellitus. J
Diabetes Investigation. 2015;6(5):567–70.
29. Gonder-Frederick LA, Fisher CD, Ritterband LM, Cox DJ, Hou L, DasGupta
AA, Clarke WL. Predictors of fear of hypoglycemia in adolescents with type
1 diabetes and their parents. Pediatr Diabetes. 2006;7(4):215–22.
30. Marrero DG, Guare JC, Vandagriff JL, Fineberg NS. Fear of hypoglycemia in
the parents of children and adolescents with diabetes: maladaptive or
healthy response? Diabetes Educ. 1997;23(3):281–6.
31. Clarke WL, Gonder-Frederick A, Snyder AL, Cox DJ. Maternal fear of
hypoglycemia in their children with insulin dependent diabetes mellitus. J
Pediatr Endocrinol Metab. 1998;11(Suppl 1):189–94.
32. Myers VH, Boyer BA, Herbert JD, Barakat LP, Scheiner G. Fear of
hypoglycemia and self reported posttraumatic stress in adults with type 1
diabetes treated by intensive regimens. J Clin Psychol Med Settings. 2007;
14:11–21.
33. Logie RDJ, De Jongh A. The “flashforward procedure”: confronting the
catastrophe. J EMDR Pract Res. 2014;8(1):25–32.
34. Cox DJ, Gonder-Frederick L, Ritterband L, Patel K, Schachinger H, Fehm-
Wolfsdorf G, Hermanns N, Snoek F, Zrebiec J, Polonsky W, et al. Blood
glucose awareness training: what is it, where is it, and where is it going?
Diabetes Spectr. 2006;19(1):43–9.
35. de Zoysa N, Rogers H, Stadler M, Gianfrancesco C, Beveridge S, Britneff E,
Choudhary P, Elliott J, Heller S, Amiel SA. A psychoeducational program to
restore hypoglycemia awareness: the DAFNE-HART pilot study. Diabetes
Care. 2014;37(3):863–6.
36. Rondags SM, de Wit M, Twisk JW, Snoek FJ. Effectiveness of HypoAware, a
brief partly web-based Psychoeducational intervention for adults with type
1 and insulin-treated type 2 diabetes and problematic hypoglycemia: a
cluster randomized controlled trial. Diabetes Care. 2016;39(12):2190–6.
37. Little SA, Leelarathna L, Walkinshaw E, Tan HK, Chapple O, Lubina-Solomon
A, Chadwick TJ, Barendse S, Stocken DD, Brennand C, et al. Recovery of
hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2
x 2 factorial randomized controlled trial comparing insulin pump with
multiple daily injections and continuous with conventional glucose self-
monitoring (HypoCOMPaSS). Diabetes Care. 2014;37(8):2114–22.
38. Martyn-Nemeth P, Schwarz Farabi S, Mihailescu D, Nemeth J, Quinn L. Fear
of hypoglycemia in adults with type 1 diabetes: impact of therapeutic
advances and strategies for prevention - a review. J Diabetes Complicat.
2016;30(1):167–77.
39. Open Science Collaboration, Psychology. Estimating the reproducibility of
psychological science. Science. 2015;349(6251):aac4716.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Nefs and Pouwer BMC Public Health  (2018) 18:156 Page 8 of 8
